- FDA Advisory Panel Recommends Approval of New RA Drug Tofacitinib is part of an up-and-coming new class of disease-modifying drugs called JAK inhibitors 5/10/12
- Obesity May Be a Risk Factor for Developing RA Being obese could increase the risk of developing rheumatoid arthritis by 20 percent 5/9/12
- One-Third of People With Arthritis Have Anxiety and Depression A new study shows these conditions are underdiagnosed – but treatment could help with pain and function 5/4/12
Get moving
the right way with our exercise videos & photos.
the right way with our exercise videos & photos.
